Sign In
Buy NEO
$10.14
+0.0200 (+0.198%)
At Close: Jun 03, 2026
3 Supercharged Stocks Near 52-Week Highs That Could Keep Climbing
06:24am, Sunday, 19'th Mar 2023
Reata Pharmaceuticals stock is soaring on the back of a recent FDA approval for a new rare disease drug. Calliditas Therapeutics stock recently jumped higher in response to positive trial results for
5 Best and Worst Performing Mid-Cap Stocks in February 2023
10:58pm, Thursday, 09'th Mar 2023
Mid-cap stocks offer a balance between stability and growth prospects. On the one hand, they offer better growth prospects than large-cap stocks, and on the other, they carry lower risk and more stabi
Investors Cash In On 12 'Triple Play' Stocks That Do No Wrong
08:00am, Tuesday, 07'th Mar 2023
Investors are worried that S&P 500 stocks will let them down. So why not focus on the handful that are delivering perfection?
NeoGenomics to Present at the 44th Annual Raymond James Institutional Investors Conference
07:00am, Tuesday, 28'th Feb 2023
FT. MYERS, FL / ACCESSWIRE / February 28, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today ann
NeoGenomics, Inc. (NEO) Q4 2022 Earnings Call Transcript
04:33pm, Thursday, 23'rd Feb 2023
NeoGenomics, Inc. (NASDAQ:NEO ) Q4 2022 Earnings Conference Call February 23, 2023 8:30 AM ET Company Participants Chris Smith - Chief Executive Officer Jeff Sherman - Chief Financial Officer Warren S
Why Shares of NeoGenomics Jumped Today
03:34pm, Thursday, 23'rd Feb 2023
The company released promising earnings results.
Why Crypto Altcoins Moved Big This Week
05:30am, Saturday, 11'th Feb 2023 The Motley Fool
The SEC's crackdown has spooked crypto traders.
Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2023
03:00pm, Wednesday, 01'st Feb 2023 Benzinga
Upgrades
According to Alembic Global, the prior rating for Woodward Inc (NASDAQ:WWD) was changed from Neutral to Overweight. Woodward earned $0.49 in the first quarter, compared to $0.56 in the year-a
Analyst Expectations for NeoGenomics's Future
01:01pm, Wednesday, 01'st Feb 2023 Benzinga
NeoGenomics (NASDAQ:NEO) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
3
1
0
0
Last 30D
1
Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
06:33pm, Thursday, 19'th Jan 2023 Benzinga
Gainers
Genius Group Limited (NYSE: GNS) jumped 87% to $1.00. Genius Group authorized issue of special dividend and appointed Timothy Murphy to lead Illegal Trading Task Force.
NeuroSense Therapeutic
Wall Street Analysts Predict a 41% Upside in NeoGenomics (NEO): Here's What You Should Know
02:55pm, Monday, 12'th Dec 2022 Zacks Investment Research
The mean of analysts' price targets for NeoGenomics (NEO) points to a 40.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analy
NeoGenomics: What The Leadership Shuffle Means
06:36pm, Friday, 09'th Dec 2022
What started as a seemingly innocuous leadership transition at one of the country's leading molecular diagnostic firms, NeoGenomics, Inc., has evolved into something much more chaotic. After the depar
NeoGenomics: Too Early To Celebrate
08:33pm, Friday, 25'th Nov 2022
NEO Q3 results carry signs of stability after tumultuous six months, which saw the company running without a CEO. It is too early to assess the performance of the current CEO, given that Q3 results ar
BrightView Holdings, America's Car-Mart And Some Other Big Stocks Moving Lower On Thursday
04:30pm, Thursday, 17'th Nov 2022 Benzinga
U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Thursday. Here are some big stocks recording losses in today’s session.
Inotiv, Inc. (NASDAQ: NOTV) shares tumbled 46.9% t
Why Shares of NeoGenomics Jumped 53.9% This Week
10:36pm, Friday, 11'th Nov 2022 The Motley Fool
The cancer screening company showed its turnaround may be working.
